Overcoming resistance to oncolytic virus M1 by targeting PI3K-γ in tumor-associated myeloid cells.
Liu Y, Xu C, Xiao X, Chen Y, Wang X, Liu W, Tan Y, Zhu W, Hu J, Liang J, Yan G, Lin Y, Cai J.
Liu Y, et al. Among authors: zhu w.
Mol Ther. 2022 Dec 7;30(12):3677-3693. doi: 10.1016/j.ymthe.2022.05.008. Epub 2022 May 11.
Mol Ther. 2022.
PMID: 35552024
Free PMC article.